Extensions

Patent Term Adjustments (PTA) and Patent Term Extensions (PTE)

Patent Term Adjustment (PTA)

US Patent 9,525,084 is subject to a terminal disclaimer and has an adjustment of 0 days. Patent Term Adjustment (PTA) can add time to a patent's term to compensate for certain administrative delays by the USPTO during patent prosecution. These delays generally fall into categories such as:

• "A delay": Failure of the USPTO to issue an office action within 14 months of filing, respond to an applicant's reply within 4 months, or issue a patent within 4 months of the issue fee payment.
• "B delay": The application pending for more than three years.
• "C delay": Delays due to interferences, secrecy orders, or successful appellate review.

Applicant delays can reduce the PTA.

Patent Term Extension (PTE)

Patent Term Extensions (PTEs) are available under 35 U.S.C. § 156 for patents claiming products that require regulatory approval, such as human drugs, medical devices, food additives, animal drugs, and veterinary biological products, to restore time lost during the premarket government approval process. There is no information to suggest that US 9,525,084 is related to a product requiring regulatory approval for a PTE.

Continuation and Divisional Applications

US Patent 9,525,084 (application Ser. No. 14/945,003) is referenced as a parent application for other patents in its family. For example, U.S. patent application Ser. No. 15/309,922 (now U.S. Pat. No. 9,818,893) is a continuation of U.S. patent application Ser. No. 14/945,003 (now U.S. Pat. No. 9,525,084).

The patent itself claims benefit from numerous provisional applications, starting with U.S. Prov. Ser. No. 62/081,538, filed on November 18, 2014, and including several others filed throughout 2015. It also relates to International Patent Appl. No. PCT/US14/39208, filed May 22, 2014, and several earlier U.S. Provisional applications dating back to May 22, 2013.

Related Family Members

The patent explicitly identifies other family members, including those with continuation-in-part or continuation relationships. Some of these include:

• U.S. Pat. No. 9,530,905 (from U.S. patent application Ser. No. 14/943,898)
• U.S. Pat. No. 9,818,893 (from U.S. patent application Ser. No. 15/309,922)
• U.S. Patent No. 10,468,543
• U.S. Patent No. 10,446,700
• U.S. Patent No. 11,621,360

These related patents share common subject matter, as indicated by references in PTAB proceedings.

Projected Expiration Date

The anticipated expiration date for US Patent 9,525,084 is November 18, 2035. This date is typically calculated as 20 years from the earliest filing date (priority date) of the non-provisional application, plus any Patent Term Adjustments (PTA) or extensions (PTE), and considering any terminal disclaimers. Given that the patent notes a 0-day adjustment and is subject to a terminal disclaimer, the expiration date is directly tied to the earliest effective filing date, which is November 18, 2015.